Angele Maki - CBO @ Callio Therapeutics - Crunchbase Person Profile

Start Free Trial

Pricing

Overview

Number of Current Board & Advisor Roles

CB Rank (Person)

452,896

Primary Job Title CBO
Primary Organization
Callio Therapeutics

Location San Francisco, California, United States
Regions San Francisco Bay Area, West Coast, Western US
Gender Female

Facebook View on Facebook
LinkedIn View on LinkedIn
X (Twitter) View on X

Angele Maki is based out of San Francisco, California and is the Chief Business Officer of Callio Therapeutics. Angele previously worked at Hummingbird Bioscience as a Chief Business Officer. Angele Maki attended Stanford University.

Jobs

Number of Current Jobs

Number of Past Jobs

Angele Maki

has

current jobs including

Board of Directors

Ability biologics

CBO

Hummingbird Bioscience

, and

CBO

Callio Therapeutics

. Additionally,

Angele Maki

has had

past jobs including

CBO

Hummingbird Bioscience

Ability biologics Board of DirectorsJun 3, 2025
Hummingbird Bioscience CBOMar 2025
Callio Therapeutics CBOFeb 2025
Eli Lilly & Company Foundation Vice President, Emerging Technology & InnovationJul 2019

Organization Name	Title At Company	Start Date	End Date
Hummingbird Bioscience	CBO	Dec 2023	Feb 2025
ReCode Therapeutics	Senior Vice President and Head of Business Development	Aug 2021	Nov 2023
Merck	Executive Director, Bus Dev & Licensing, West Coast Innovation Hub	Oct 2017	Jun 2019
23andMe	Director, Business Development	Jan 2017	Sep 2017
Bristol-Myers Squibb	Director, Strategic Transactions Group	Oct 2009	Nov 2011

Board and Advisor Roles

Number of Current Board & Advisor Roles

Angele Maki

holds

board and advisor roles including

Leadership Team/Director/Board Member

Canadian Entrepreneurs in Life Science(CELS)

Biotech Industry Advisory Council Member

Pear VC

, and

Advisor

Paradox Immunotherapeutics

Canadian Entrepreneurs in Life Science(CELS) Leadership Team/Director/Board MemberDec 2023
Pear VC Biotech Industry Advisory Council MemberNov 2023
Paradox Immunotherapeutics AdvisorApr 2021

Related Hubs

Hub Name	CB Rank (Hub)
Norwest Portfolio Companies	54,272
Western US Biotechnology Companies with Early Stage Venture Funding	48,607
EDBI Portfolio Companies	65,162
Medical Early Stage Companies With Fewer Than 50 Employees	43,521
Omega Funds Portfolio Companies	90,918
Seeds Capital Portfolio Companies	86,629
United States Medical Companies with Early Stage Venture Funding	49,613
Novo Holdings Portfolio Companies	84,514
United States Early Stage Companies With Fewer Than 10 Employees	34,596
Medical Early Stage Companies With Fewer Than 10 Employees	63,479